Mesenchymal stem cells negatively regulate CD4<sup>+</sup> T cell activation in patients with primary Sjögren syndrome through the miRNA‑125b and miRNA‑155 TCR pathway-Reference-Cited by-同舟云学术

Mesenchymal stem cells negatively regulate CD4⁺ T cell activation in patients with primary Sjögren syndrome through the miRNA‑125b and miRNA‑155 TCR pathway

Published:2020-11-10 Issue:1 Volume:23 Page:1-1
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Gong Bangdong¹,Zheng Ling²,Lu Zhenhao¹,Huang Jiashu¹,Pu Jincheng¹,Pan Shengnan¹,Zhang Min¹,Liu Jie³,Tang Jianping¹

Affiliation:

1. Division of Rheumatology, Tongji Hospital of Tongji University School of Medicine, Shanghai 200065, P.R. China

2. Division of Respiratory Medicine, Tongji Hospital of Tongji University School of Medicine, Shanghai 200065, P.R. China

3. Center for Regenerative Medicine, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cause and consequence of heterogeneity in human mesenchymal stem cells: Challenges in clinical application;Pathology - Research and Practice;2024-08

2. Role of ncRNAs in the Pathogenesis of Sjögren’s Syndrome;Biomedicines;2024-07-11

3. Clinical features and risk factors of primary Sjögren’s syndrome complicated with severe pneumonia: a case–control study;Clinical Rheumatology;2024-03-21

4. COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers;Medical Oncology;2024-01-02

5. sFgl2 gene-modified MSCs regulate the differentiation of CD4+ T cells in the treatment of autoimmune hepatitis;Stem Cell Research & Therapy;2023-11-03